Heartflow, Inc. (HTFL)
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Healthcare Information Services
Heartflow, Inc. Common Stock
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 52.45 | 53.49 | 51.06 | 52.40 | 969,878 |
| Nov 5, 2026 | 56.27 | 56.78 | 51.70 | 51.95 | 2,147,179 |
| Nov 4, 2026 | 54.59 | 57.30 | 54.53 | 56.57 | 1,592,498 |
| Nov 3, 2026 | 54.30 | 56.95 | 54.00 | 54.40 | 1,468,343 |
| Nov 2, 2026 | 59.14 | 60.00 | 54.36 | 54.49 | 1,648,070 |
| Oct 30, 2026 | 59.00 | 59.55 | 56.93 | 59.05 | 2,247,288 |
| Oct 29, 2026 | 59.00 | 60.56 | 58.50 | 60.53 | 1,299,737 |
| Oct 28, 2026 | 58.06 | 60.29 | 56.42 | 59.10 | 1,644,138 |
| Oct 27, 2026 | 56.95 | 59.90 | 55.99 | 57.82 | 1,794,085 |
| Oct 26, 2026 | 57.31 | 57.55 | 56.32 | 57.01 | 1,058,739 |
| Oct 23, 2026 | 55.27 | 57.74 | 54.60 | 56.71 | 1,556,316 |
| Oct 22, 2026 | 55.01 | 56.72 | 54.45 | 55.43 | 1,296,275 |
| Oct 21, 2026 | 55.60 | 57.25 | 55.33 | 55.82 | 1,577,593 |
| Oct 20, 2026 | 51.92 | 56.30 | 51.00 | 55.59 | 3,026,866 |
| Oct 19, 2026 | 48.70 | 51.78 | 48.70 | 51.02 | 1,603,574 |
| Oct 16, 2026 | 50.64 | 50.99 | 47.97 | 48.29 | 1,023,937 |
| Oct 15, 2026 | 48.37 | 51.84 | 47.39 | 50.91 | 1,503,990 |
| Oct 14, 2026 | 49.46 | 50.87 | 48.85 | 49.46 | 1,616,350 |
| Oct 13, 2026 | 50.84 | 51.57 | 49.91 | 50.32 | 1,493,891 |
| Oct 12, 2026 | 49.75 | 51.69 | 49.18 | 50.56 | 1,415,708 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Rogers Campbell | Chief Medical Officer | Option Exercise | 12.3K | -- | Oct 22, 2026 |
| Rogers Campbell | Chief Medical Officer | Option Exercise | 5.1K | $11.3K | Oct 22, 2026 |
| Rogers Campbell | Chief Medical Officer | Option Exercise | 5.1K | -- | Oct 22, 2026 |
| Rogers Campbell | Chief Medical Officer | Sale | 23.9K | $1.32M | Oct 22, 2026 |
| Rogers Campbell | Chief Medical Officer | Option Exercise | 12.3K | $102.7K | Oct 22, 2026 |
 Farquhar John C.M. | Chief Executive Officer | Sale | 38.9K | $1.93M | Oct 12, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BCLS Fund III Investments, LP · may incl. warrants· filed May 2026 | 10.4M | 12.0% | 13G |
Wellington Management Group LLP · also on 13F· joint filing· may incl. warrants· filed Aug 2026 | 9.2M | 10.6% | 13G |
Bain Capital Life Sciences Investors, LLC | 8.4M | 9.7% | 13F |
WELLINGTON MANAGEMENT GROUP LLP | 7.9M | 9.0% | 13F |
HealthCor Partners Management LP · may incl. warrants· filed Nov 2025 | 6.7M | 7.7% | 13G |
BlackRock, Inc. | 5.2M | 6.0% | 13F |
FMR LLC | 4.8M | 5.5% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | 4.1% | 13F |
BAMCO INC /NY/ | 3.2M | 3.7% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | 3.2% | 13F |
Insiders
- Rogers CampbellChief Medical Officer
- Farquhar John C.M.Chief Executive Officer
- Verghese VikramChief Financial Officer
- Jones Marie L.Chief Accounting Officer
- Lightcap Jeffrey CDirector
- BARABE TIMOTHY CDirector
- WELDON WILLIAM CDirector
- Cullivan Julie ADirector
- Tansey Casey MDirector
- Riley Wayne JosephDirector
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease.
Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
based on 86.95M shares outstanding
US30d Avg
1.60M
60d Avg
1.78M
90d Avg
2.03M